Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients

Amino Acids

Volumn 32, Issue 1, 2007, Pages 121-126

  Fekkes, D ^a   Bannink, M ^a   Kruit, W H J ^a   Van Gool, A R ^a   Mulder, P G H ^a   Sleijfer, S ^a   Eggermont, A M M ^a   Stoter, G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arginine; Citrulline; Interferon; Melanoma; Nitric oxide

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARGININE; CITRULLINE; NEUROLEPTIC AGENT; NITRIC OXIDE; PEGYLATED INTERFERON ALPHA; RECOMBINANT INTERFERON;

ADULT; AGED; AMINO ACID BLOOD LEVEL; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ANTIVIRAL AGENTS; ARGININE; CITRULLINE; FEMALE; HUMANS; INTERFERON ALFA-2B; MALE; MELANOMA; NITRIC OXIDE; RISK FACTORS; TIME FACTORS;

EID: 33845240174     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-006-0284-3     Document Type: Conference Paper

References (31)

1. PJ Andrew B Mayer 1999 Enzymatic function of nitric oxide synthases Cardiovascular Res 43 521 531
2. C Bogdan 2001 Nitric oxide and the immune response Nat Immunol 2 907 916
3. S Bonaccorso V Marino A Puzella M Pasquini M Biondi M Artini C Almerighi R Verkerk H Meltzer M Maes 2002 Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system J Clin Psychopharmacol 22 86 90
4. RM Bukowski C Tendler D Cutler E Rose MM Laughlin P Statkevich 2002 Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation Cancer 95 389 396
5. R Busse A Mülsch 1990 Induction of nitric oxide synthase by cytokines in vascular smooth muscle cell FEBS Lett 275 87 90
6. WE Chrapko P Jurasz MW Radomski N Lara SL Archer JM Le Mellédo 2004 Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder Biol Psychiatry 56 129 134
7. E Dieperink M Willenbring SB Ho 2000 Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review Am J Psychiatry 157 867 876
8. G Dusheiko 1997 Side effects of alpha interferon in chronic hepatitis C Hepatology 26 112S 121S
9. D Fekkes A van Dalen M Edelman A Voskuilen 1995 Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde J Chromatogr B Biomed Appl 669 177 186
10. PJ Goodnick BJ Goldstein 1998 Selective serotonin reuptake inhibitors in affective disorders-I. Basic pharmacology J Psychopharmacol 12 S5 S20
11. AJ Harkin KH Bruce B Craft IA Paul 1999 Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test Eur J Pharmacol 372 207 213
12. EC Hurlock 4th 2001 Interferons: potential roles in affect Med Hypotheses 56 558 566
13. B Karolewicz KH Bruce B Lee IA Paul 1999 Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in downregulation of cortical beta-adrenoceptors Eur J Pharmacol 372 215 220
14. JP Kiss 2000 Role of nitric oxide in the regulation of monoaminergic neurotransmission Brain Res Bull 52 459 466
15. J [tmp] MacMicking Q-W Xie C Nathan 1997 Nitric oxide and macrophage function Annu Rev Immunol 15 323 350
16. M Maes HY Meltzer 1995 The serotonin hypothesis of major depression FE Bloom DJ Kupfer Psychopharmacology: the fourth generation of progress Raven Press New York 933 944
17. AM Mathewson RM Wadsworth 2004 Induction of iNOS restricts functional activity of both eNOS and nNOS in pig cerebral artery Nitric Oxide 11 331 339
18. ML Pall 2002 Levels of the nitric oxide synthase product, citrulline, are elevated in sera of chronic fatigue syndrome patients J Chronic Fatigue Syndr 10 37 41
19. H Prast A Philippu 2001 Nitric oxide as modulator of neuronal function Prog Neurobiol 64 51 68
20. M Salter C Duffy J Garthwaite PJLM Strijbos 1996 Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo J Neurochem 66 1683 1690
21. HHW Schmidt U Walter 1994 NO at work Cell 78 919 925
22. AI Sharara DJ Perkins MA Misukonis SU Chan JA Dominitz JB Weinberg 1997 Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo J Exp Med 186 1495 1502
23. N Srivastana MK Barthwal PK Dalal AK Agarwal D Nag PK Seth RC Srimal M Dikshit 2002 A study on nitirc oxide, β-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression J Affect Dis 72 45 52
24. E Suzuki G Yagi T Nakaki S Kanba M Asai 2001 Elevated plasma nitrate levels in depressive states J Affect Dis 63 221 224
25. E Suzuki Y Yoshida A Shibuya H Miyaoka 2003 Nitric oxide involvement in depression during interferon-alpha therapy Int J Neuropsychopharmacol 6 415 419
26. PC Trask P Esper M Riba B Redman 2000 Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions J Clin Oncol 18 2316 2326
27. D Tsikas JC Frölich 2004 Trouble with the analysis of nitrite, nitrate, S-nitrosothiols and 3-nitrotyrosine: freezing-induced artifacts? Nitric Oxide 11 209 213
28. JG Van Amsterdam A Opperhuizen 1999 Nitric oxide and biopterin in depression and stress Psychiatry Res 85 33 38
29. AR Van Gool WHJ Kruit FK Engels G Stoter M Bannink AMM Eggermont 2003a Neuropsychiatric side effects of interferon-alfa therapy Pharm World Sci 25 11 20
30. AR Van Gool D Fekkes WHJ Kruit PGH Mulder TL Ten Hagen M Bannink M Maes AMM Eggermont 2003b Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients Psychiatry Res 119 125 132
31. AR Van Gool HH van Ojik WHJ Kruit M Bannink PGH Mulder AMM Eggermont G Stoter D Fekkes 2004 Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations Anticancer Drugs 15 587 591